This page contains brief information about avelumab and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.
Use in Cancer
Avelumab is approved to treat:
- Merkel cell carcinoma that has metastasized (spread to other parts of the body). It is used in adults and in children aged 12 years or older.
Avelumab is also being studied in the treatment of other types of cancer.
More About Avelumab
Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.
Research Results and Related Resources
Clinical Trials Accepting Patients
Find Clinical Trials for Avelumab - Check for trials from NCI's list of cancer clinical trials now accepting patients.